Clinical Study of Decitabine and Paclitaxel Combination Therapy

Clinical trial NCT03282825 · UNKNOWN

Trial details

NCT number: NCT03282825
Sponsor: Dong Wha Pharmaceutical Co. Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Breast Cancer

Start date: 2017-03-28
Primary completion: 2018-02-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.